Latest Breaking News On - சோதனை நோயியல் - Page 1 : comparemela.com

Inaugural ARUP Laboratories Symposium Offers Strategies to Help Lab Leaders Advance Their Labs Value in Their Healthcare Systems

Press release content from PR Newswire. The AP news staff was not involved in its creation.

New yorkUnited statesSandy richmanBrian jacksonLisa carricaburuJon burnsMichaelj dowlingGaurav sharmaAndrew fletcherAlison flynn gaffneyConsultative servicesUniversity of utahPrnewswire northwell healthCenters for medicareInstitute for clinicalLaboratory medicine

Hypoxic inflammation leads to inefficient cardiac repair after heart attacks

Activation of hypoxia inducible factors (green) in macrophages (purple) that have infiltrated damaged cardiac tissue (right) in heart tissue.

United statesMatthew debergeEdward thorpEmily hendersonDivision of experimental pathologyNorthwestern medicineExperimental pathologyHeart attackHeart failureMyocardial infarctionஒன்றுபட்டது மாநிலங்களில்எட்வர்ட் தோர்ப்எமிலி ஹென்டர்சன்வடமேற்கு மருந்துசோதனை நோயியல்

Deep Bio Collaborates with ARUP in AI Clinical Implementation Research

Deep Bio Collaborates with ARUP in AI Clinical Implementation Research
prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.

Soult ukpyolsiSouth koreaUnited statesBeatrice knudsenResearch collaboration agreementUniversity of utahBio incSamds in vitro diagnostics softwareInstitute for clinicalDepartment of pathologyResearch programDeep bioSun woo kimVitro diagnostics softwareMedical deviceExperimental pathology

Aggressive type of cancer provides clues to how metastases form

Aggressive type of cancer provides clues to how metastases form A very aggressive type of cancer has provided a team of researchers supported by the Swiss National Science Foundation with an answer to the question of which tumor cells are at risk of spreading. Cancer treatment is sometimes complicated by the heterogeneity of the cells that form the tumor mass. The problem is how to identify the few cells that are capable of triggering metastases. Thanks to work carried out by a team of researchers supported by the Swiss National Science Foundation (SNSF), we now have a better understanding of how metastases form and which cells to target in therapy.

Ivan stamenkovicNicolo riggiEmily hendersonUniversity hospital lausanneSwiss national science foundationExperimental pathologyஎமிலி ஹென்டர்சன்சுவிஸ் தேசிய அறிவியல் அடித்தளம்சோதனை நோயியல்

ARUP Laboratories Reduces Turnaround Time on Panel Analysis by 30% with GenomOncology

ARUP Laboratories Reduces Turnaround Time on Panel Analysis by 30% with GenomOncology
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesAlysia kaplanPrnewswire genomoncologySteven friedmanCyndee privitt holdenJon frettholdMarketing communicationsInstitute for clinicalDepartment of pathologyUniversity of utahPrecision oncologyTherapy matchingClinical variant scientistVariant scientistsNew york qualified